Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Standard therapy for patients with myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Azacytidine for the treatment of myelodysplastic syndromes in the elderly.

    ... The management of myelodysplastic syndromes (MDS) in elderly patients is a significant clinical problem. The ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Rationale for the Clinical Application of Flow Cytometry in Patients with Myelodysplastic Syndromes

    ... to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes.

    ... Advances in the treatment of myelodysplastic syndromes (MDSs) over the last decade have given patients and their ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Risk stratification in myelodysplastic syndromes: is there a role for gene expression profiling?

    ... in the hematopoietic stem cells of patients with myelodysplastic syndromes . J Clin Oncol 31(28), 3557-64 (2013). Patients with myelodysplastic syndromes (MDS) exhibit wide heterogeneity in clinical ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. The Myelodysplastic Syndromes: The Era Of Understanding

    ... Myelodysplastic syndromes are a heterogeneous group of clonal haematological stem cell ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. Prognostic factors and risk models in myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) encompass a hematologically diverse group of neoplastic ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Myelodysplastic syndromes in children: where are we today?

    ... Myelodysplastic syndromes (MDSs) and other myeloproliferative disorders (MPDs) are rare ...

    Research Article last updated 07/20/2018 - 5:14pm.

  9. Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox

    ... Myelodysplastic syndromes are characterized by ineffective hematopoiesis resulting ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010.

    ... The incidence rate of the myelodysplastic syndromes (MDS) in the United States is approximately 3.4 per 100,000 ...

    Research Article last updated 07/20/2018 - 5:14pm.